

LONDON, Feb 6 (Reuters) - Shell has chosen PricewaterhouseCoopers (PwC) as its next auditor after a tender process, with PwC set to replace EY fro...


(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday.


(Alliance News) - NatWest Group PLC and Rightmove PLC have announced a partnership that will give home buyers an "instant" digital NatWest mortgage de...


(Alliance News) - Victrex PLC on Friday maintained annual guidance despite "subdued performance" by certain markets in the first quarter.


(Sharecast News) - Shore Capital initiated coverage of Capita on Friday with 'buy' rating as it said the company's ambition and strategy to return to ...


LONDON, Feb 6 (Reuters) - Shell will pause new investments in Kazakhstan due to a series of legal proceedings launched by the government against the...


(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:


LONDON, Feb 6 (Reuters) - Shell will pause new investments in Kazakhstan due to a series of legal proceedings launched by the government against th...


(Alliance News) - Stock prices in London opened lower on Friday, as renewed fears around artifical intelligence investment spread from the US while so...


LONDON, Feb 6 (Reuters) - Japan's snap election, a heavy dose of key U.S. data, earnings season, plus a slide in (some) tech shares suggest there w...


(Alliance News) - GSK PLC on Friday said the European Commission has approved Nucala, or mepolizumab, as add-on therapy for adults with chronic obstru...


LONDON, Feb 6 (Reuters) - European data and analytics shares fell in early trading on Friday, continuing this week's steep drops prompted by wor...


(Sharecast News) - Analysts at Berenberg hiked their target price on serviced offices and coworking business International Workspace Group from 270p t...


(Alliance News) - UK house prices rise more sharply than expected, GSK wins approval for Nucala to treat chronic obstructive pulmonary disease in the ...


(Sharecast News) - Drugmaker GSK said on Friday that the European Commission has approved Nucala (mepolizumab) as an add‑on maintenance treatmen...